IMMUNOLOGICAL AND PHYSIOLOGICAL RESPONSES IN HORSES AND CAMELS AGAINST PAKISTANI VIPER VENOM IMMUNIZATION FOR SNAKE ANTIVENOM IMMUNOGLOBULIN PRODUCTION
Main Article Content
Keywords
Immunization, Antivenom, Immunoglobulins G, Echis carinatus sochureki, Daboia russelii, Echis carinatus multisquamatus, Viper snakes, Pakistan
Abstract
The treatment for snakebite victims is antivenom immunoglobulins. Modern immunization methods for horses and camels with Pakistani viper venoms are rare, despite maintaining animal safety and efficacy. The study aimed to assess the horses' and camels' immunoglobulins production response against Pakistani viper snake venoms. Throughout immunization, each horse (N=3) and camel (N=3) was immunized with Echis carinatus sochureki, Daboia russelii, and Echis carinatus multisquamatus venoms using Freund’s complete or incomplete adjuvants following previously reported low-dose multi-site immunization method. The study compared the Lumps size, body weight, total protein, albumin, and globulin concentration every 15 days, recorded body temperature for three days after each immunization dose, and confirmed immunoglobulin G production through double immune diffusion gel diffusion and SDS-PAGE electrophoresis. The study found that Freund's complete and incomplete adjuvant induced reactions (lumps) were more significant in camels than in horses (p < 0.05). No significant weight gain or loss was noted (p > 0.05). After immunization, the increase in body temperature was temporary, and horses were more stable than camels. Total protein and globulin concentrations increased after the 3rd and 4th immunization doses, while albumin concentrations decreased in horses and camels significantly (p < 0.05) compared to their basal concentrations. The antigen-antibody precipitin line in double immune diffusion gel diffusion and IgG bands in SDS-PAGE gel confirmed the development of snake antivenom immunoglobulins against viper venoms. In conclusion, horses and camels showed positive response to producing antivenom immunoglobulins against Pakistani viper venoms, but camels experienced severe physical impact compared to horses.
References
2. Harrison RA, Hargreaves A, Wagstaff SC, Faragher B, Lalloo DG. Snake envenoming: a disease of poverty. PLoS neglected tropical diseases. 2009;3(12):e569.
3. Ralph R, Sharma SK, Faiz MA, Ribeiro I, Rijal S, Chappuis F, et al. The timing is right to end snakebite deaths in South Asia. bmj. 2019;364.
4. Mohapatra B, Warrell DA, Suraweera W, Bhatia P, Dhingra N, Jotkar RM, et al. Snakebite mortality in India: a nationally representative mortality survey. PLoS neglected tropical diseases. 2011;5(4):e1018.
5. Parveen G, Khan M, Ali H, Ibrahim T, Shah R. Determination of lethal dose (LD50) of venom of four different poisonous snakes found in Pakistan. Biochem Mol Biol J. 2017;3(3):18.
6. Chippaux J-P. Guidelines for the production, control and regulation of snake antivenom immunoglobulins. Biologie aujourd'hui. 2010;204(1):87-91.
7. Pratanaphon R, Akesowan S, Khow O, Sriprapat S, Ratanabanangkoon K. Production of highly potent horse antivenom against the Thai cobra (Naja kaouthia). Vaccine. 1997;15(14):1523-8.
8. Christensen P. Production and standardization of antivenin. Snake venoms: Springer; 1979. p. 825-46.
9. Theakston RDG, Warrell D, Griffiths E. Report of a WHO workshop on the standardization and control of antivenoms. Toxicon. 2003;41(5):541-57.
10.Cook DA, Owen T, Wagstaff SC, Kinne J, Wernery U, Harrison RA. Analysis of camelid IgG for antivenom development: Serological responses of venom-immunised camels to prepare either monospecific or polyspecific antivenoms for West Africa. Toxicon. 2010;56(3):363-72.
11.Harrison R, Wernery U. The unique properties of camelid IgG have potential to improve the treatment of snake bite. 2007.
12.Ratanabanangkoon K, Tan KY, Pruksaphon K, Klinpayom C, Gutiérrez JM, Quraishi NH, et al. A pan-specific antiserum produced by a novel immunization strategy shows a high spectrum of neutralization against neurotoxic snake venoms. Scientific Reports. 2020;10(1):11261.
13.Bermúdez-Méndez E, Fuglsang-Madsen A, Føns S, Lomonte B, Gutiérrez JM, Laustsen AH. Innovative immunization strategies for antivenom development. Toxins. 2018;10(11):452.
14.Milovanović V, Dimitrijević L, Petrušić V, Kadrić J, Minić R, Živković I. Application of the 3R concept in the production of European antiviperinum on horses–Multisite, low volumes immunization protocol and ELISA. Acta veterinaria. 2018;68(4):401-19.
15.Angulo Y, Estrada R, Gutiérrez J. Clinical and laboratory alterations in horses during immunization with snake venoms for the production of polyvalent (Crotalinae) antivenom. Toxicon. 1997;35(1):81-90.
16.Padula AM, Winkel KD. Antivenom production in the alpaca (Vicugna pacos): physiological and antibody responses to monovalent and polyvalent immunisation with Australian elapid venoms. Small ruminant research. 2016;141:63-9.
17.Waghmare A, Salvi N, Deopurkar R, Shenoy P, Sonpetkar J. Evaluation of health status of horses immunized with snake venom and montanide adjuvants, IMS 3012 (nanoparticle), ISA 206 and ISA 35 (emulsion based) during polyvalent snake antivenom production: Hematological and biochemical assessment. Toxicon. 2014;82:83-92.
18.Khamehchian S, Zolfagharian H, Dounighi NM, Tebianian M, Madani R. Study on camel IgG purification: A new approach to prepare Naja naja oxiana antivenom as passive immunization for therapy. Human vaccines & immunotherapeutics. 2014;10(6):1633-8.
19.Omidfar K, Rasaee MJ, Kashanian S, Paknejad M, Bathaie Z. Studies of thermostability in Camelus bactrianus (Bactrian camel) single‐domain antibody specific for the mutant epidermal‐growth‐factor receptor expressed by Pichia. Biotechnology and applied biochemistry. 2007;46(1):41-9.
20.Sriprapat S, Aeksowan S, Sapsutthipas S, Chotwiwatthanakun C, Suttijitpaisal P, Pratanaphon R, et al. The impact of a low dose, low volume, multi-site immunization on the production of therapeutic antivenoms in Thailand. Toxicon. 2003;41(1):57-64.
21.Barnett P, Pullen L, Williams L, Doel T. International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants. Vaccine. 1996;14(13):1187-98.
22.Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J biol Chem. 1949;177(2):751-66.
23.Rodkey FL. Direct spectrophotometric determination of albumin in human serum. Clinical Chemistry. 1965;11(4):478-87.
24.Ouchterlony Ö. Antigen-antibody reactions in gels. 1949.
25.Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. nature. 1970;227(5259):680-5.
26.Harrison R, Hasson S, Harmsen M, Laing G, Conrath K, Theakston RDG. Neutralisation of venom-induced haemorrhage by IgG from camels and llamas immunised with viper venom and also by endogenous, non-IgG components in camelid sera. Toxicon. 2006;47(3):364-8.
27.Tu A. Handbook of Natural Toxins: Reptile Venoms and Toxins: CRC Press; 1991.
28.Chatterjee S, Dass B, Devi P. A comparative study on different methods of hyperimmunization of horses for the preparation of polyvalent anti-snake venom serum. 1968.
29.Stewart-Tull D, Rowe R. Procedures for large-scale antiserum production in sheep. Journal of immunological methods. 1975;8(1-2):37-45.
30.Husby G, Kyle RA. Nomenclature and classification of amyloid and amyloidoses. Journal of internal medicine. 1992;232(6):511-2.
31.Gade S, Khadilkar M. Studies on some hematological parameters of Indian mules. 2005.
32.Netto D, Chiacchio SB, Bicudo P, Alfieri A, Balarim M, Nascimento N. Hematological changes in sheep inoculated with natural and Cobalt60-irradiated Crotalus durissus terrificus venom (Laurenti, 1768). Journal of Venomous Animals and Toxins including Tropical Diseases. 2004;10:34-52.
33.Chanhome L, Puempunpanich S, Omori-Satoh T, Chaiyabutr N, Sitprija V. A pilot experiment for production of Malayan krait antivenom: immunization of rabbits with Bungarus candidus venom. Journal of Natural Toxins. 2002;11(4):353-6.
34.Norouznejad N, Zolfagharian H, Babaie M, Ghobeh M. Purification of Therapeutic Serums of Snake Anti-Venom with Caprylic Acid. Journal of Pharmacopuncture. 2022;25(2):114.
35.Warrell DA. Snake venoms in science and clinical medicine 1. Russell's viper: biology, venom and treatment of bites. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1989;83(6):732-40.
36.Meddeb-Mouelhi F, Bouhaouala-Zahar B, Benlasfar Z, Hammadi M, Mejri T, Moslah M, et al. Immunized camel sera and derived immunoglobulin subclasses neutralizing Androctonus australis hector scorpion toxins. Toxicon. 2003;42(7):785-91.
37.Darvish M, Ebrahimi SA, Shahbazzadeh D, Bagheri K-P, Behdani M, Shokrgozar MA. Camelid antivenom development and potential in vivo neutralization of Hottentotta saulcyi scorpion venom. Toxicon. 2016;113:70-5.
38.Gupta D, Ahmed F, Tandel D, Parthasarathy H, Vedagiri D, Sah V, et al. Development of Equine Immunoglobulin Fragment F (ab’) 2 with High Neutralizing Capability against SARS-CoV-2. BioRxiv. 2021:2021.03. 09.434030.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Zahoor Ahmed
Assistant Professor, Institute of Public Health, Faculty of Community Medicine & Health Sciences, People’s University of Medical and Health Sciences for Women, Nawabshah 67450 & Institute of Biochemistry, University of Sindh, Jamshoro, Pakistan.
Naseem Aslam Channa
Professor & Director at Institute of Biochemistry, University of Sindh, Jamshoro 71000, Pakistan.
Shazia Parveen Solangi
Assistant Professor, Department of Biochemistry, Shah Abdul Latif University, Khairpur, Pakistan.
Zeba Hussain Soomro
Neurobiochemist, Dr Ruth KM Pfau Civil Hospital Karachi 74400, Pakistan.
Saud Farooque
Assistant Professor, Institute of Public Health, Faculty of Community Medicine & Health Sciences, People’s University of Medical and Health Sciences for Women, Nawabshah 67450 & Institute of Biochemistry, University of Sindh, Jamshoro, Pakistan.
Zulfiqar Ali Dahri
Institute of Biochemistry, University of Sindh, Jamshoro 71000, Pakistan.
Naeem H. Quraishi
Consultant at Snake Antivenom/Anti-rabies Serology Laboratory, Government of Sindh, Nawabshah 67450, Pakistan.